01 7Aricept
02 1Namzaric
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 89
2018 Revenue in Millions : 116
Growth (%) : -23
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 255
2019 Revenue in Millions : 340
Growth (%) : -25
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 208
2020 Revenue in Millions : 245
Growth (%) : -9
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 187
2021 Revenue in Millions : 208
Growth (%) : -10.1
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 156
2022 Revenue in Millions : 184
Growth (%) : -5
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 429
2016 Revenue in Millions : 448
Growth (%) : -4
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 357
2017 Revenue in Millions : 402
Growth (%) : -11%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 333
2018 Revenue in Millions : 369
Growth (%) : -10
LOOKING FOR A SUPPLIER?